{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:37:12Z","timestamp":1792521432240,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,2,11]],"date-time":"2010-02-11T00:00:00Z","timestamp":1265846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,2,11]],"date-time":"2010-02-11T00:00:00Z","timestamp":1265846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00431-010-1142-6","type":"journal-article","created":{"date-parts":[[2010,2,10]],"date-time":"2010-02-10T18:29:52Z","timestamp":1265826592000},"page":"925-933","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles\u2013mumps\u2013rubella\u2013varicella vaccine to children aged 11\u201321\u00a0months"],"prefix":"10.1007","volume":"169","author":[{"given":"Markus","family":"Knuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Zepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius U.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirmin","family":"Habermehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns-Michael","family":"Burow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Behre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmtrud","family":"Bisanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruprecht","family":"Schmidt-Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,11]]},"reference":[{"key":"1142_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10198-003-0200-7","volume":"5","author":"K Banz","year":"2004","unstructured":"Banz K, Wagenpfeil S, Neiss A et al (2004) The burden of varicella in Germany. Potential risks and economic impact. Eur J Health Econ 5:46\u201353","journal-title":"Eur J Health Econ"},{"key":"1142_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1017\/S0950268802007720","volume":"129","author":"PY Boelle","year":"2002","unstructured":"Boelle PY, Hanslik T (2002) Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect 129:599\u2013606","journal-title":"Epidemiol Infect"},{"key":"1142_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s00431-005-1637-8","volume":"164","author":"J Bonhoeffer","year":"2005","unstructured":"Bonhoeffer J, Baer G, Muehleisen B et al (2005) Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr 164:366\u2013370","journal-title":"Eur J Pediatr"},{"key":"1142_CR4","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/adc.2007.123232","volume":"92","author":"JC Cameron","year":"2007","unstructured":"Cameron JC, Allan G, Johnston F et al (2007) Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child 92:1062\u20131066","journal-title":"Arch Dis Child"},{"key":"1142_CR5","volume-title":"The Pink book","author":"Centers for Disease Control and Prevention","year":"2007","unstructured":"Centers for Disease Control and Prevention (2007) Epidemiology and prevention of vaccine-preventable diseases. In: Atkinson W, Hamborsky J, McIntyre L, Wolfe S (eds) The Pink book, 10th edn. Public Health Foundation, Washington, DC","edition":"10"},{"key":"1142_CR6","first-page":"285","volume":"45","author":"C Clements","year":"1992","unstructured":"Clements C, Strassburg M, Cutts FT et al (1992) The epidemiology of measles. World Health Stat Q 45:285\u2013291","journal-title":"World Health Stat Q"},{"key":"1142_CR7","unstructured":"Committee for Medicinal products for Human use (CHMP) (2006) European Public Assessment Report on MMRV. http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/proquad\/062206en6.pdf"},{"issue":"2","key":"1142_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/vim.2007.0113","volume":"21","author":"HA Gans","year":"2008","unstructured":"Gans HA, Yasukawa LL, Zhang CZ et al (2008) Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants. Viral Immunol 21(2):163\u2013172","journal-title":"Viral Immunol"},{"key":"1142_CR9","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1016\/j.vaccine.2004.04.004","volume":"22","author":"A Gil","year":"2004","unstructured":"Gil A, San-Martin M, Carrasco P et al (2004) Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine 22:3947\u20133951","journal-title":"Vaccine"},{"key":"1142_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1741-7015-7-16","volume":"7","author":"Y Gillet","year":"2009","unstructured":"Gillet Y, Habermehl P, Thomas S et al (2009) Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial. BMC Med 7:16","journal-title":"BMC Med"},{"key":"1142_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s15010-007-6337-z","volume":"35","author":"P Goh","year":"2007","unstructured":"Goh P, Lim FS, Han HH et al (2007) Safety and immunogenicity of early vaccination with two doses of tetravalent measles\u2013mumps\u2013rubella\u2013varicella (MMRV) vaccine in healthy children from 9\u00a0months of age. Infection 35:326\u2013333","journal-title":"Infection"},{"key":"1142_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1651-2227.2007.00595.x","volume":"97","author":"V Grote","year":"2008","unstructured":"Grote V, von Kries R, Springer W et al (2008) Varicella-related deaths in children and adolescents\u2014Germany 2003\u20132004. Acta Ped 97:187\u2013192","journal-title":"Acta Ped"},{"key":"1142_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1017\/S0950268808001131","volume":"137","author":"JM Guillen","year":"2008","unstructured":"Guillen JM, de la Luz Samaniego-Colmenero M, Hernandez-Barrera V et al (2008) Varicella paediatric hospitalizations in Spain. Epidemiol Infect 137:519\u2013525","journal-title":"Epidemiol Infect"},{"issue":"12","key":"1142_CR14","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1086\/588195","volume":"197","author":"R Hanna-Wakim","year":"2008","unstructured":"Hanna-Wakim R, Yasukawa LL, Sung P et al (2008) Immune responses to mumps vaccine in adults who were vaccinated in childhood. J Infect Dis 197(12):1669\u20131675","journal-title":"J Infect Dis"},{"key":"1142_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1001\/archpedi.158.4.323","volume":"158","author":"M Ipp","year":"2004","unstructured":"Ipp M, Cohen E, Goldbach M et al (2004) Effect of choice of measles\u2013mumps\u2013rubella vaccine on immediate vaccination pain in infants. Arch Pediatr Adolesc Med 158:323\u2013326","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"1142_CR16","first-page":"e296","volume":"13","author":"M Ipp","year":"2006","unstructured":"Ipp M, Cohen E, Goldbach M et al (2006) Pain response to M\u2013M\u2013R vaccination in 4\u20136\u00a0year old children. Can J Clin Pharmacol 13(3):e296\u2013e299","journal-title":"Can J Clin Pharmacol"},{"issue":"5","key":"1142_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/archpediatrics.2009.35","volume":"163","author":"M Ipp","year":"2009","unstructured":"Ipp M, Parkin PC, Lear N et al (2009) Order of vaccine injection and infant pain response. Arch Pediatr Adolesc Med 163(5):469\u2013472","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1142_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","volume":"25","author":"M Knuf","year":"2006","unstructured":"Knuf M, Habermehl P, Zepp F et al (2006) Immunogenicity and safety of two doses of tetravalent measles\u2013mumps\u2013rubella\u2013varicella vaccine in healthy children. Pediatr Infect Dis J 25:12\u201318","journal-title":"Pediatr Infect Dis J"},{"key":"1142_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.2.5.3246","volume":"2","author":"BJ Kuter","year":"2006","unstructured":"Kuter BJ, Brown ML, Hartzel J et al (2006) Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad). Hum Vaccin 2:205\u2013214","journal-title":"Hum Vaccin"},{"issue":"12","key":"1142_CR20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/nri959","volume":"2","author":"A Lanzavecchia","year":"2002","unstructured":"Lanzavecchia A, Sallusto F (2002) Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol 2(12):982\u2013987","journal-title":"Nat Rev Immunol"},{"key":"1142_CR21","first-page":"314","volume":"9","author":"SM Marcy","year":"2003","unstructured":"Marcy SM (2003) Pediatric combination vaccines: their impact on patients, providers, managed care organizations, and manufacturers. Am J Manag Care 9:314\u2013320","journal-title":"Am J Manag Care"},{"key":"1142_CR22","first-page":"1","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin M, Guris D, Chaves SS et al (2007) Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56:1\u201340","journal-title":"MMWR Recomm Rep"},{"key":"1142_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1086\/315714","volume":"182","author":"PA Meyer","year":"2000","unstructured":"Meyer PA, Seward JF, Jumaan AO et al (2000) Varicella mortality: trends before vaccine licensure in the United States, 1970\u20131994. J Infect Dis 182:383\u2013390","journal-title":"J Infect Dis"},{"key":"1142_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00006454-199601000-00011","volume":"15","author":"AL Ngai","year":"1996","unstructured":"Ngai AL, Staehle BO, Kuter BJ et al (1996) Safety and immunogenicity of one vs. two injections of Oka\/Merck varicella vaccine in healthy children. Pediatr Infect Dis J 15:49\u201354","journal-title":"Pediatr Infect Dis J"},{"key":"1142_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0264-410X(02)00459-0","volume":"21","author":"T Nolan","year":"2002","unstructured":"Nolan T, McIntyre P, Roberton D et al (2002) Reactogenicity and immunogenicity of a live attenuated tetravalent measles\u2013mumps\u2013rubella\u2013varicella (MMRV) vaccine. Vaccine 21:281\u2013289","journal-title":"Vaccine"},{"key":"1142_CR26","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1016\/j.vaccine.2008.08.052","volume":"26","author":"H Petousis-Harris","year":"2008","unstructured":"Petousis-Harris H (2008) Vaccine injection technique and reactogenicity\u2014evidence for practice. Vaccine 26:6299\u20136304","journal-title":"Vaccine"},{"key":"1142_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1542\/peds.2005-0092","volume":"117","author":"KS Reisinger","year":"2006","unstructured":"Reisinger KS, Hoffman Brown ML et al (2006) A combination measles, mumps, rubella and varicella vaccine (ProQuad) given to 4- to 6- year-old healthy children vaccinated previously with M\u2013M\u2013RII and Varivax. Pediatrics 117:265\u2013272","journal-title":"Pediatrics"},{"key":"1142_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/01.inf.0000122606.88429.8f","volume":"23","author":"B Rentier","year":"2004","unstructured":"Rentier B, Gershon AA, The members of EuroVar the European Working Group on Varicella (EuroVar) (2004) A consensus paper: varicella vaccination of healthy children\u2014a challenge for Europe. Pediatr Infect Dis J 23:379\u2013389","journal-title":"Pediatr Infect Dis J"},{"key":"1142_CR29","first-page":"235","volume":"30","author":"Robert Koch-Institut","year":"2006","unstructured":"Robert Koch-Institut (2006) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: Juli 2006. Epidemiol Bulletin 30:235\u2013254","journal-title":"Epidemiol Bulletin"},{"key":"1142_CR30","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/INF.0b013e318170bb22","volume":"27","author":"V Schuster","year":"2008","unstructured":"Schuster V, Otto W, Maurer L et al (2008) Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles\u2013mumps\u2013rubella\u2013varicella vaccine in healthy children during the second year of life. Pediatr Infect Dis J 27:724\u2013730","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1142_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0022-1759(98)00004-0","volume":"212","author":"MA Suni","year":"1998","unstructured":"Suni MA, Picker LJ, Maino VC (1998) Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods 212(1):89\u201398","journal-title":"J Immunol Methods"},{"key":"1142_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/01.inf.0000250689.09396.21","volume":"26","author":"T Vesikari","year":"2007","unstructured":"Vesikari T, Baer M, Willems P (2007) Immunogenicity and safety of a second dose of measles\u2013mumps\u2013rubella\u2013varicella vaccine in healthy children aged 5 to 6\u00a0years. Pediatr Infect Dis J 26:153\u2013158","journal-title":"Pediatr Infect Dis J"},{"key":"1142_CR33","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/INF.0b013e3180616c8f","volume":"26","author":"T Vesikari","year":"2007","unstructured":"Vesikari T, Sadzot-Delvaux C, Rentier B et al (2007) Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine. Pediatr Infect Dis J 26:632\u2013638","journal-title":"Pediatr Infect Dis J"},{"issue":"Issue 2","key":"1142_CR34","first-page":"1","volume":"2003","author":"World Health Organization Europe","year":"2002","unstructured":"World Health Organization Europe (2002) Measles surveillance in the European region. EURO Measles Q 2003(Issue 2):1\u20134","journal-title":"EURO Measles Q"},{"key":"1142_CR35","first-page":"130","volume":"79","author":"World Health Organization","year":"2004","unstructured":"World Health Organization (2004) Measles vaccines. Wkly Epidemiol Rec 79:130\u2013142","journal-title":"Wkly Epidemiol Rec"},{"key":"1142_CR36","first-page":"51","volume":"82","author":"World Health Organization","year":"2007","unstructured":"World Health Organization (2007) Mumps virus vaccines. Wkly Epidemiol Rec 82:51\u201360","journal-title":"Wkly Epidemiol Rec"},{"key":"1142_CR37","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00431-007-0506-z","volume":"166","author":"F Zepp","year":"2007","unstructured":"Zepp F, Behre U, Kindler K et al (2007) Immunogenicity and safety of a tetravalent measles\u2013mumps\u2013rubella\u2013varicella vaccine co-administered with a booster dose of a combined diphtheria\u2013tetanus\u2013acellular pertussis\u2013hepatitis B-inactivated poliovirus\u2013Haemophilus influenzae type b conjugate vaccine in healthy children aged 12\u201323\u00a0months. Eur J Pediatr 166:857\u2013864","journal-title":"Eur J Pediatr"},{"key":"1142_CR38","unstructured":"Zepp F, Manegold-Randel D, Helm K, et al (2008) Antibody persistence and varicella breakthrough case assessment three years after administration of measles\u2013mumps\u2013rubella\u2013varicella (MMRV) vaccine in children aged 11\u201323\u00a0months [abstract]. Program and abstracts of the 26th Annual Meeting of the European Society of Paediatric Infectious Diseases (Graz, Austria)"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1142-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-010-1142-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1142-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1142-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:25:40Z","timestamp":1659057940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-010-1142-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,11]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["1142"],"URL":"https:\/\/doi.org\/10.1007\/s00431-010-1142-6","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,11]]},"assertion":[{"value":"19 November 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}